Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFBK
951
DELISTED
Northfield Bancorp
NFBK
| $6.5M | 0.02% |
+555,038
| New | +$6.43M |
|
952
Albany International
AIN
$2.16B
| $6.49M | 0.02% |
+196,900
| New | +$6.06M |
|
|
PSB
953
DELISTED
PS Business Parks, Inc.
PSB
| $6.49M | 0.02% |
+89,900
| New | +$6.99M |
|
954
NETSCOUT
NTCT
$2.89B
| $6.47M | 0.02% |
+277,300
| New | +$6.44M |
|
|
TRLG
955
DELISTED
TRUE RELIGION APPAREL INC
TRLG
| $6.43M | 0.02% |
+203,000
| New | +$5.99M |
|
956
Hasbro
HAS
$13.6B
| $6.41M | 0.02% |
+143,000
| New | +$6.51M |
|
957
Magnachip Semiconductor
MX
$118M
| $6.4M | 0.02% |
+350,231
| New | +$5.89M |
|
958
LiveRamp
RAMP
$2.29B
| $6.38M | 0.02% |
+281,145
| New | +$5.89M |
|
|
TESS
959
DELISTED
Tessco Technologies Inc
TESS
| $6.38M | 0.02% |
+241,500
| New | +$5.33M |
|
960
Apogee Enterprises
APOG
$873M
| $6.37M | 0.02% |
+265,252
| New | +$6.9M |
|
961
Park-Ohio Holdings
PKOH
$564M
| $6.34M | 0.02% |
+192,400
| New | +$6.91M |
|
962
American Water Works
AWK
$27B
| $6.33M | 0.02% |
+153,600
| New | +$6.34M |
|
963
InterContinental Hotels
IHG
$23.9B
| $6.33M | 0.02% |
+161,282
| New | +$6.69M |
|
964
Insulet
PODD
$11.6B
| $6.33M | 0.02% |
+201,600
| New | +$5.71M |
|
|
PRXL
965
DELISTED
Parexel International Corp
PRXL
| $6.32M | 0.02% |
+137,500
| New | +$6.04M |
|
|
ALR
966
DELISTED
AlerisLife Inc
ALR
| $6.31M | 0.02% |
+112,550
| New | +$6.12M |
|
967
CVR Partners
UAN
$1.29B
| $6.31M | 0.02% |
+27,750
| New | +$6.83M |
|
968
Anika Therapeutics
ANIK
$202M
| $6.3M | 0.02% |
+370,703
| New | +$5.35M |
|
|
SYMM
969
DELISTED
SYMMETRICOM INC
SYMM
| $6.3M | 0.02% |
+1,403,319
| New | +$6.82M |
|
|
GPX
970
DELISTED
GP Strategies Corp.
GPX
| $6.3M | 0.02% |
+264,500
| New | +$6.09M |
|
|
WCG
971
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.28M | 0.02% |
+113,000
| New | +$6.31M |
|
|
WAGE
972
DELISTED
WageWorks, Inc.
WAGE
| $6.27M | 0.02% |
+181,900
| New | +$5.14M |
|
|
IMOS
973
ChipMOS TECHNOLOGIES
IMOS
$1.73B
| $6.24M | 0.02% |
+292,771
| New | +$5.3M |
|
|
APOL
974
DELISTED
Apollo Education Group Inc Class A
APOL
| $6.24M | 0.02% |
+352,125
| New | +$6.71M |
|
975
Teleflex
TFX
$5.94B
| $6.23M | 0.02% |
+80,400
| New | +$6.45M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.